PlainRecalls
FDA Drug Low Class III Terminated

Esterified Estrogens & Methyltestosterone Tablets, USP 0.625 mg/1.25 mg, 100-count bottles, Rx Only, Manufactured by: Ammeal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Seton Pharmaceuticals Manasquan, NJ 08736, NDC 13925-171-01

Reported: July 10, 2019 Initiated: September 25, 2017 #D-1438-2019

Product Description

Esterified Estrogens & Methyltestosterone Tablets, USP 0.625 mg/1.25 mg, 100-count bottles, Rx Only, Manufactured by: Ammeal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Seton Pharmaceuticals Manasquan, NJ 08736, NDC 13925-171-01

Reason for Recall

Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.

Details

Units Affected
19104 units
Distribution
Nationwide within the United States
Location
Brookhaven, NY

Frequently Asked Questions

What product was recalled?
Esterified Estrogens & Methyltestosterone Tablets, USP 0.625 mg/1.25 mg, 100-count bottles, Rx Only, Manufactured by: Ammeal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Seton Pharmaceuticals Manasquan, NJ 08736, NDC 13925-171-01. Recalled by Amneal Pharmaceuticals, Inc.. Units affected: 19104 units.
Why was this product recalled?
Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 10, 2019. Severity: Low. Recall number: D-1438-2019.